HER2-targeting ADC FS-1502

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

HER2-targeting ADC FS-1502

Jun 21, 2024, 11:16 | Insight

Paolo Tarantino: Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published in Nature Communications

Paolo Tarantino shared on X/Twitter: "Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published…

All: 1 Posts: 1 - 100

'

Aladina Foundation was Honored with the Yvonne Humanitarian Award by OncoDaily

'

Rod Stewart and Prostate Cancer: How He Went Against, How He Survived, and More

'

Kimryn Rathmell: The year in cancer - 24 advances in 2024

'

Celebrating the Holiday Magic with Medical Community

'

Melanie Griffith and Skin Cancer: How She Went Against, How She Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023